Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel M Kenney

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Hospital Pharmacy|August 12, 2021
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push AdministrationChristian M Gill, Rachel M Kenney, Charles T Makowski, et al.
Infectious Diseases and Therapy|March 8, 2017
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsLauren K Flynt, Rachel M Kenney, Marcus J Zervos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Ambulatory Quinolone Prescribing: Moving From Opportunity to ImplementationNicholas J Mercuro, Rachel M Kenney, Odaliz Abreu-Lanfranco, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Secular trends associated with Enterobacteriaceae with a cefepime susceptible-dose-dependent MICJamie L Wagner, Rachel M Kenney, Robert J Tibbetts, et al.
Pharmacotherapy|December 16, 2017
Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program ActivitiesKayla R Stover, Rachel M Kenney, Samuel Travis King, et al.
Sexually Transmitted Diseases|May 6, 2024
Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis After 2021 Sexually Transmitted Infection Treatment Guideline UpdateChristen J Arena, Rachel M Kenney, Erin Eriksson, et al.
Infection Control and Hospital Epidemiology|September 29, 2021
Outcomes of clinical decision support for outpatient management of <i>Clostridioides difficile</i> infectionTiffany Wu, Susan L Davis, Brian Church, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 15, 2024
Judicious Use of Benzathine Penicillin G in Response to a Medication Alert During a Critical Drug ShortageWilliam Campillo Terrazas, Rachel M Kenney, Amy Argyris, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 27, 2024
Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infectionChristen J Arena, Rachel M Kenney, Mayur Ramesh, et al.
The Annals of Pharmacotherapy|November 14, 2016
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT)Joseph J Carreno, Rachel M Kenney, George Divine, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Hospital Pharmacy|August 12, 2021
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push AdministrationChristian M Gill, Rachel M Kenney, Charles T Makowski, et al.
Infectious Diseases and Therapy|March 8, 2017
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsLauren K Flynt, Rachel M Kenney, Marcus J Zervos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Ambulatory Quinolone Prescribing: Moving From Opportunity to ImplementationNicholas J Mercuro, Rachel M Kenney, Odaliz Abreu-Lanfranco, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Secular trends associated with Enterobacteriaceae with a cefepime susceptible-dose-dependent MICJamie L Wagner, Rachel M Kenney, Robert J Tibbetts, et al.
Pharmacotherapy|December 16, 2017
Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program ActivitiesKayla R Stover, Rachel M Kenney, Samuel Travis King, et al.
Sexually Transmitted Diseases|May 6, 2024
Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis After 2021 Sexually Transmitted Infection Treatment Guideline UpdateChristen J Arena, Rachel M Kenney, Erin Eriksson, et al.
Infection Control and Hospital Epidemiology|September 29, 2021
Outcomes of clinical decision support for outpatient management of <i>Clostridioides difficile</i> infectionTiffany Wu, Susan L Davis, Brian Church, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 15, 2024
Judicious Use of Benzathine Penicillin G in Response to a Medication Alert During a Critical Drug ShortageWilliam Campillo Terrazas, Rachel M Kenney, Amy Argyris, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 27, 2024
Outcomes of adjunctive eravacycline for severe and fulminant Clostridioides difficile infectionChristen J Arena, Rachel M Kenney, Mayur Ramesh, et al.
The Annals of Pharmacotherapy|November 14, 2016
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT)Joseph J Carreno, Rachel M Kenney, George Divine, et al.
Pageof 7